2,4-thiazolidinedione has been researched along with Weight Loss in 6 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Weight loss is the best treatment option, which can be a challenging task for patients to achieve and maintain." | 2.46 | Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management. ( Brown, A; Desai, M; Taneja, D; Tannock, LR, 2010) |
| "Type 2 diabetes mellitus is a major cause of morbidity and mortality worldwide, and the prevalence is set to increase dramatically over the coming decades." | 2.43 | Etiology of insulin resistance. ( Petersen, KF; Shulman, GI, 2006) |
| "For now, the goals and methods of treating hypertension and dyslipidemia are the same in people with the metabolic syndrome as in the general population." | 2.41 | A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia. ( Hoogwerf, BJ; Nambi, V; Sprecher, DL, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, A | 1 |
| Desai, M | 1 |
| Taneja, D | 1 |
| Tannock, LR | 1 |
| Nambi, V | 1 |
| Hoogwerf, BJ | 2 |
| Sprecher, DL | 1 |
| Petersen, KF | 1 |
| Shulman, GI | 1 |
| Zinman, B | 1 |
| Durán García, S | 1 |
| Milton, DR | 1 |
| Giaconia, JM | 1 |
| Kim, DD | 1 |
| Trautmann, ME | 1 |
| Brodows, RG | 1 |
| Castro Cabezas, M | 1 |
| Halkes, CJ | 1 |
| Erkelens, DW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin[NCT00099320] | Phase 3 | 182 participants (Actual) | Interventional | 2004-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for 2,4-thiazolidinedione and Weight Loss
| Article | Year |
|---|---|
Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
Topics: Amyloid; Bariatric Surgery; Diabetes Mellitus; Diet, Reducing; Dipeptidyl-Peptidase IV Inhibitors; E | 2010 |
A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hyperinsulinism; Hypertension; Hypertrigly | 2002 |
Etiology of insulin resistance.
Topics: Diabetes Mellitus, Type 2; Glucose Transporter Type 4; Humans; Hypoglycemic Agents; Insulin Receptor | 2006 |
Obesity and free fatty acids: double trouble.
Topics: Chylomicrons; Coronary Artery Disease; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperlipid | 2001 |
1 trial available for 2,4-thiazolidinedione and Weight Loss
| Article | Year |
|---|---|
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Double-Blind M | 2007 |
1 other study available for 2,4-thiazolidinedione and Weight Loss
| Article | Year |
|---|---|
Summaries for patients. Exenatide therapy for type 2 diabetes.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Exenatide; F | 2007 |